BU-NOT-SET

CONTACT US
Faster, smaller, smarter: Intelligent manufacturing of mRNA through the power of process analytical technologies
  • Biologics
  • Manufacturing
Man in lab
Webinar
ReciBioPharm: The Economic Case for Continuous Manufacturing
  • Biologics
two people looking at a paper
Insight
The innovation bottleneck: Why drug development is so tough, and how connectivity and predictive analysis can overcome obstacles
  • Drug product
  • Manufacturing
logo recipredict
Insight
What are the key trends shaping drug development in 2025?
  • Industry trends
containers
Insight
ReciBioPharm Is Advancing xRNA Production
  • Biologics
xRNA
Insight
Navigating the complexities of pre-filled syringes for biologics
  • Drug product
  • Manufacturing
syringes
eBook
Unlocking the potential of mRNA with robust lyophilisation strategies
  • Drug product
  • Manufacturing
containers
Insight
Advanced Bio Is Advancing AAV Production
  • Biologics
Recipharm_AdvancedBio_Adeno associated virus
Insight
Advanced is advancing xRNA manufacturing
  • Biologics
Recipharm_AdvancedBio_lab
Insight
White paper
  • Analytical chemistry
  • Drug substance
Analysing prebiotic oligosaccharides for future product innovation
Insight
  • Industry trends
  • Manufacturing
Enhancing sterile processing for future vaccine programs
Insight
  • Sustainability
Increasing carbon emission transparency through SBTi contributions
Insight
  • Biologics
Single-use technologies are enabling increasing demand for biologics
Insight
  • Biologics
Overcoming the challenges surrounding manufacturing oncolytic viruses
Insight
  • Drug product
  • Industry trends
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
White paper
  • Analytical chemistry
  • Drug product
Developing a robust dissolution method for low-dose formulations
Report
  • Sustainability
Sustainability report 2022
Insight
  • Drug product
  • Industry trends
Navigating the changing oral solid dose landscape